Nicole Mittmann

Impact of aggressive management and palliative care on cancer costs in the final month of life

Matthew C. Cheung, Craig C. Earle, Jagadish Rangrej et al. · Cancer · 2015 · 184 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial

Nicole Mittmann, H. Au, D. Tu et al. · JNCI Journal of the National Cancer Institute · 2009 · 141 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population‐based retrospective matched cohort analysis

Lisa Barbera, Rinku Sutradhar, Hsien Seow et al. · Cancer Medicine · 2020 · 114 citations · Full text

Nursing, Biostatistics, Oncology +13

Impact of Standardized Edmonton Symptom Assessment System Use on Emergency Department Visits and Hospitalization: Results of a Population-Based Retrospective Matched Cohort Analysis

Lisa Barbera, Rinku Sutradhar, Hsien Seow et al. · JCO Oncology Practice · 2020 · 96 citations

Public Health, Biostatistics, Oncology +15

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

Kelvin Chan, Helen Guo, Sierra Cheng et al. · Cancer Medicine · 2019 · 91 citations · Full text

Medicine, Oncology, Pharmacotherapy +12